Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record now presents details for the Phase 1/2 RAMP203 study of avutometinib and sotorasib, with or without defactinib, in KRAS G12C non-small cell lung cancer. It includes participant eligibility, study arms and outcome measures, participating locations, and record dates.
    Difference
    70%
    Check dated 2026-11-09T14:44:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updates from v3.7.2 to v3.8.0, while the study record area remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:18:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:50:54.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:39:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:58:48.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now appears, replacing the full study record and preventing viewing the trial details. The error page shows a minimal header with 403 Forbidden, indicating an access issue rather than content.
    Difference
    19%
    Check dated 2026-09-21T21:50:02.000Z thumbnail image

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.